company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3879000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,59900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3938900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,673200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,673200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3265700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1680200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,718100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,121300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2546400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,719300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,94600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,664400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,177400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,487000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,485300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,484800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.59
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2007.0,FY,2007-01-01,2007-12-31,2010-02-26 17:14:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.59
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4339700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,63700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4403400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,761200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,761200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3642200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1856100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,797900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,150900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,41300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2846200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,796000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,85500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,18200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,762200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,197500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,564700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,564700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,563100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.84
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 21:52:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1081900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,16300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1098200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,194700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,194700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,903500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,440400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,186600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,39300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,666100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,237400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,233000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,166000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,166000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,165400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,306300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,306300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 16:22:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1155800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,16200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1172000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,974500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,506900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,213400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,35800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,765500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,209000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,189900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,143800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,143400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,305100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,305100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,305100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 18:24:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4447600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4503600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,750900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,750900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3752700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1921500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,706000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,146300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,50900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2824700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,928000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,76900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,848500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,224700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,623800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,623800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,621300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.03
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,FY,2009-01-01,2009-12-31,2012-02-28 14:58:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1206500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,17800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1224300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,184600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,184600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1039700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,497600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,185400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,36200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,722800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,316900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,295800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,73000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,223100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,223100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,221500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1127800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,13500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1141300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,951100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,497500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,176900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,36000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,714600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,236500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-12400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,232300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,53100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,179200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,179200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,179000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 16:28:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3241100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,38200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3279300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,566300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,566300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2713000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1423900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,520600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,110100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,47300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2101900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,611100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-32900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,552700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,151700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,400700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,400700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,399800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.32
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.31
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.32
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1118700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,12100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1130800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,198300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,198300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,932500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,441900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,161600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,35500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,640000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,292500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-35500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,257000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,80200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,176800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,176800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,176100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 14:35:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2113300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2138000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,376100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,376100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1761900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,926400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,343700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,43100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1387300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,374600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,320400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,98600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,221500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,221500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,220800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,994600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,12600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1007200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,177800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,177800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,829400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,484500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,182100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,38600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,42100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,747300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,82100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,63400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,298000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,298000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,298000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:29:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4819600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,99800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4919400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,722000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,722000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4197400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2017600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,804600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,138000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,369100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3938800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,258600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,78700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-87800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,170800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,165900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,FY,2010-01-01,2010-12-31,2012-02-28 14:58:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1290100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,19200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1309300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,182800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,182800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1126500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,527500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,200300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,32500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-609900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,759100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,367400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,333000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,69900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,263100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,263100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,263100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.87
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.87
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1192000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,16200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1208200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,177700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,177700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1030500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,517300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,194000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,31100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,369100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,609900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1721500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-691000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-727700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-59000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-668700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-668700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-670500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.21
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.21
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 19:08:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.21
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3529500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,80600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3610100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,539200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,539200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3070900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1490100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,604300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,105500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,369100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,609900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3179700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-108800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,50900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-162200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,96000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-258200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-258200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-262500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.87
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.88
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.87
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4736000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,98400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4834400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,723800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,723800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4110600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1987700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,789700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,141700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,369100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,609900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3902500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,208100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,72100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-74500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,133600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,169000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1231700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,15500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1247200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,191300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,191300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1055900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,499000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,37300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,724000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,331900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,92000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,241500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,241500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,240100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.79
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.78
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 16:49:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.79
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2337500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,64400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2401900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,361500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,361500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2040400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,972800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,410300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1458200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,582200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,30500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,565500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,155000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,410500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,410500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,408000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4671800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,95700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4767500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,736300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,736300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4031200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1967900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,772600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,146600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2895600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1135600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,69500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1093600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,281100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,812800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,812800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,808500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.66
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.63
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,303900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.66
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1105800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,48900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1154700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,170200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,170200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,984500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,473800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,222700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,37100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,734200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,250300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,232000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,63000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,169000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,169000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,167900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 16:35:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4558800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,92300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4651100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,743300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,743300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3907800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1910800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,746600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,144800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2811600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1096200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,74100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1017100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,269300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,748100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,748100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,744500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.45
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.43
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,305300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.45
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5144000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,72000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5216000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,718000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,718000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4498000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2158300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,871500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,86100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3123400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1374600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,71800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1309200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,359600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,949600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-11500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,938100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,934500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,FY,2011-01-01,2011-12-31,2014-02-25 14:42:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1179700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,19500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1199200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,151300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,151300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1047900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,463600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-9500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-16100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,628400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,419500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,393200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,102000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-11500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,279700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,279800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1311100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,17300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1328400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,188100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,188100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1140300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,538500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,221300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,31900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,795900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,344400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,356800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,105800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,251000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,251000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,249800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.82
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:34:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.82
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3964300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,52500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4016800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,566700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,566700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3450100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1694700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,676400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,95600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,23700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2495000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,955100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,916000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,257600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,658400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,658400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,654700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5254400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,71700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5326100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,749500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,749500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4576600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2222200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,876700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,128100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,23700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-609900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3254100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1322500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,82900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-73500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1249000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,327500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,921500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,921500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,917800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,308400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.99
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1400400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,16800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1417200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,195300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,195300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1221900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,566700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,257400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,31200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,858700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,363200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,344000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,95400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,248600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,248600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,246600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,312200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 14:00:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2653200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,35200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2688400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,378600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,378600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2309800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1156200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,455100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,63700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,19400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1699100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,610700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,39900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,559200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,151800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,407400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,407400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,404900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,312200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.3
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5135300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,70600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5205900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,739100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,739100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4466800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2201000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,849400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,127300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,388500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4179700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,287100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,88100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-43100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-122600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,164500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,162700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,312200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.03
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1252800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,18400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1271200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,183300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,183300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1087900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,589500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,197700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,32500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,16100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,840400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,247500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-32300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,215200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,158800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,158300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1,2011-01-01,2011-03-31,2012-05-07 17:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4966600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,69300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5035900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,735100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,735100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4300800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2133300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,779600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,133400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,609200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,385200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4045000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,255800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,86800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,154000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,159300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.03
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,304400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.03
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1447800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1472100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,183000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,183000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1289100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,542300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,239800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,22300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,827400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,461700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,445000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,122700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,322300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,325200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,324200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,301900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,301900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5549300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,97300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5646600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,751200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,751200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4895400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2193100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,977300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,90200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,22300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3284400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1611000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,63600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-80000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1531000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,430300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1100700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1102500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1098800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,301900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.64
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,306900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,301900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,FY,2012-01-01,2012-12-31,2015-02-18 20:14:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.64
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4101500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,73000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4174500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,568200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,568200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3606300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1650800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,737500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,67200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2457000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1149300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-19300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1086000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,307600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,778400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,777300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,774600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,304100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5281200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,92500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5373700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,719500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,719500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4654200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2114400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,932600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,57700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-16100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3085400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1568800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1479200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,409600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1069600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-12600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1057000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1054400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,304100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.42
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1353700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,22800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1376500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,182900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,182900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1193600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,522900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,289800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,22800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,836100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,357500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,334300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,81400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,252900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-2300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,250600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,249400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,304100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.82
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,300500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 16:27:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2747800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,50200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2798000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,385300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,385300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2412700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1127900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,447700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,44400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1620900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,791800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,32900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-40100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,751700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,226200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,525500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,526700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,525200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.7
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5238600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,87000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5325600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,724700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,724700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4600900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2130000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,864100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,66800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-11800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3045200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1555700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,64800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1501700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1067700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-10300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1057400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1054800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.48
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.41
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.48
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1426100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,24000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1450100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,195300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,195300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1254800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,563100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,227700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,23100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,814800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,440000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,429500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,132400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,297100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,296400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,295400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,307700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,301400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 17:01:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5212900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,79800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5292700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,724700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,724700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4568000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2133600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,893800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-8500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3089100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1478900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,62900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-62700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1416200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,397000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1019200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-9600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1009600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1006000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,302400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.31
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.24
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,302400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.31
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1321700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,26200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1347900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1157900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,564800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,220000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,21300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,806100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,351800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-15000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,322200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,93800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,228400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,230300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,229800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,302400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,310500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,302400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:42:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-2832800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-2859900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-688700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-688700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-2171200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-606600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-84400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-357500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-22800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-667900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-1743500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-427700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,114400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-125400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-553100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-311700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-241400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-24300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-265700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-263700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.54
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.53
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2602500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2602500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1644700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1644700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,957800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,456100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,374800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,303800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1327000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-369200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,239800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-18600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-253600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-622800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-155300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-467500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-282900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-750400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-750400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,142300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,142300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,142400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,FY,2013-01-01,2013-12-31,2016-02-26 08:04:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2013000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2013000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1083200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1083200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,929800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,223600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,163700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,146300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,13600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,779300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,150500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,52900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,96900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,31400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3,2013-07-01,2013-09-30,2014-11-05 17:04:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5435300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5462400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2333400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2333400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3129000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1062700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,459200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,548800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,326600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,668900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3070500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,58500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,125400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-128200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-69700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,156400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-226100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-258600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-484700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-486700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.77
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6883100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,51400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6934500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2516400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2516400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4418100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1605000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,459200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,788600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,349600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,669800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,21400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3897900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,520200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,140200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-144900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,375300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,279100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,96200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-255700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-162500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.66
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.68
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,131200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.66
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1989800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1989800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1050300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1050300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,939500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,225800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,235600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,136300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,149600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,647500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1402600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-463100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-513200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-564600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-564600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-564800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:35:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3422300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3449400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1250200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1250200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2199200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,830600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,235600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,385100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,180300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,655300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2291200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-92000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,72500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-74600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-166600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,125000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-291600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-258600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-550200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-552300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.23
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.23
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.27
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6223800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,74200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6298000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1616100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1616100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4681900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1895800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,235600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,914700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,226100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,669800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3954700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,727200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,103200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-114500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,612700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,329100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,283600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-258000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,132200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.35
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,132300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5660100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,98200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5758300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,761100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,761100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4997200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2233100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1006100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,99600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,22300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3366900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1630300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-74900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1555400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,410100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1145300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-258700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,886600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,881500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.88
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1432500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1459600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,199900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,199900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1259700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,604800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,248800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,30700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,888600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,371100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,346600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,73600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,273000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-258600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,312500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 09:32:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-2796600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-2796600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-2067800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-2067800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-728800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-48800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-305400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,383700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,708300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,970400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1699200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,127800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-149400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1848600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-380600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1468000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,734800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-733200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-732900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.31
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.3
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4676500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4676500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1704800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1704800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2971700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1201400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1066000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,605700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1935800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,730000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5538900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2567200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,411800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-431000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2998200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-513600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2484600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,854100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1630500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1630500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,219700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.42
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,219700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.42
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,219700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,FY,2014-01-01,2014-12-31,2017-02-24 17:06:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.42
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2150800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2150800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1183100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1183100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,967700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,422900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,540200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,581600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,705000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2249700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1282000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,132100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1383100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-221000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1162100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,119300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1042800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1042800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.95
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.95
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,264000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:32:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.95
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7473100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7473100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3772600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3772600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3700500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,968800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1114800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,911100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1552100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,21700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4568500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-868000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,284000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-281600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1149600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-133000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1016600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,119300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-897300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-897600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.12
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.09
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4640300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4613200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3083900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3083900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1529300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,362200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1030400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,553600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1529300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-646200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2825000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1295700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,398400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-13000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-407000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1702700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-444700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1258000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,95000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1163000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1161300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.65
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.65
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,235400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-13.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2667200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2667200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1296500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1296500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1370700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,270100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,291500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,158000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,422900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,22100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1164600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,206100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,79100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-113700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,92400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,173900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 09:27:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5322300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5322300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2589500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2589500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2732800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,545900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,574600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,329500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,847100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,21700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2318800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,414000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,151900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-180500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,233500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,145500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,145500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,145200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-85400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.66
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4502500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4475400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2984000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2984000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1491400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,171400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,713800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,135700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,970600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-632600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1354600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,136800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,319200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-44500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-359500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-222700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-192300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-24300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-52900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,174200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,175000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-85400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.9
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2655100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2655100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1293000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1293000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1362100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,275800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,283100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,171500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,424200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1154200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,207900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,72800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-66800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,141100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,44400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,96700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,96700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,96500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,172300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 09:16:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3825100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-27100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3798000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2737800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2737800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1060200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,127100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,657900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,114000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,697300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1592600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-532400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,295200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-295900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-828300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-184500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-643800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-24300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-668100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-666400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,173800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.75
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,174900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.76
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-31200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.6
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15715400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15715400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2855400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2855400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12860000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,517200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,710400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,444600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1582400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9936300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,268900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13459800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-599800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,341300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-334300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-934100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-126100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-2806200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3614200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7039700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4054800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-629300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-162400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-135400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-333100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,367800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,367800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,404700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9660800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9660800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2648200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2648200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7012600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1199200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2054700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2425500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3861300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9543800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2531200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,852000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-238100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1082200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3613400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1479800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2133600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6682300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4548700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,162400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4383700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.64
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.64
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.64
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6864200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6864200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,580400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,580400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6283800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1431800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2005900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2120100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4245000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,711400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10514200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4230400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,979800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-264000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1231600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5462000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1860400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3601600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7417100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3815500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,162400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3650800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.34
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3469500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3469500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,710300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,710300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2759200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,683600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1560500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1557800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-4400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4136600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1377400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,340200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-336500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1713900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-838900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-875000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6177600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5302600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5231600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,13.29
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.29
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,393600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q3,2015-07-01,2015-09-30,2016-11-04 17:16:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.29
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6191300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6191300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1937900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1937900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4253400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,860100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1371100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,865000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2303500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5407200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1153800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,511800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-238300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-745700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1899500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-640900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1258600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,504700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-753900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,92800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-847900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.65
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.65
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,390900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.65
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5545500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5545500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1053200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1053200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4492300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1515600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1862500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1141200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3392200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,715800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8627300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4135000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,771700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-234800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-996200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5131200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1242500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3888700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1358800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2529900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,92800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2623600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.91
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.9
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,390900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.91
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3628700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3628700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,917800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,917800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2710900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,319600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,801500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,547300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1515700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3187000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-476100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,339900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-377700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-853800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-381900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-471900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,230300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-241600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-312700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,392600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,390900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:05:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4584000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4584000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1431900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1431900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3152100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1466100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1352500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,751900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2299400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,735000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6604900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3452800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,510900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-230200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-732200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4185000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-817000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3368000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1128500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2239500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,23200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2262200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,289500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-9.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,289500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-9.82
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,289300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-9.83
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2562600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2562600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1020100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1020100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1542500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,540500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,569600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,317700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,787800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2220200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-677700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,171900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-197900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-368000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1045700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-259000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-786700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,274400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-512300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,23200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-535200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,289500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,289500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,289300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 09:18:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14570600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14570600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14570600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1473900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3266400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3319600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,1860800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6470400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16396100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1825500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1295600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,219200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1006500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2832000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1897000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-817300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1752300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31829000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-15097200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14979500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14973400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,384900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,38.18
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,384900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,38.18
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,392200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,38.18
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:44:23+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,465000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,465000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1861300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,440000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,836800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1657200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,1398600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,48800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-287900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4093500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2232200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,292700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-211300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2443500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1071200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,514900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-857400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31557700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-15097200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15603100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-208800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,270200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15539200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,384900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,384900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,392200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3622200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3622200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3622200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,361200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,796000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,622800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,462200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1609100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,37300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3888600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-266400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,324300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-272600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-539000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-158900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-380100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-380100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-451500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,38.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,38.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,38.58
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 18:02:08+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14105600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14105600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12709300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1033900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2429600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1662400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,462200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6421600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12302600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,406700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1002900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,184200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-795200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-388500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-825800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1332200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-894900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,271300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-623600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,208800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-270200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-565800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,37.61
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,37.61
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,37.61
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29821000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29821000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4251700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4251700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25569300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1551100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3140000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2107000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,462200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8004000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9936300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,561800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25762400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-193100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1344200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,26200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1129500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1322600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-951900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4138400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4509100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7311000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4054800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1252900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-405600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-898900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,36.98
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,36.98
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,-11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,36.98
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3684800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3684800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,441500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,441500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3243300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,343200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,866800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,636500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1633100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,251300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3730900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-487600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,345800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-193200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-680800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-258200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-422600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-77300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-499900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-571300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.44
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.44
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,396700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 07:32:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.44
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10483400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10483400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1396300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9087100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,672700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1633600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1039600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4812500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,255600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8414000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,673100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,678600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-522600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,150500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-666900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1332200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-514800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,271300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-243500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,139200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-270200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-114300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.97
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.97
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,396700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.97
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29668300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29668300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4962000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4962000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24706300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1529000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3027600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3044700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7952700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9936300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,520100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26010400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1304100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1360100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,155100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1193400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2497500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1631900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4138400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5004000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,13488600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4054800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4429800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-405600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4784200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.69
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,395600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.69
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,396700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.69
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29612200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29612200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5438300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5438300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24173900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1505400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2962300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2955500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7835300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9936300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,271700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25466500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1292600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1354200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1377900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2670500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1755600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4138400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5053300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,13796200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4054800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4688100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-405600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5042800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,394800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,394800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,972300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.33
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15940700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15940700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2168000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2168000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13772700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1501900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3514800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3552400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7197100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3927700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19693900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5921200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1095600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3437300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4465200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10386400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6670400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3716000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-402900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4118900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,278400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4403900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,333800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-13.19
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,333800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-13.19
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,333900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,FY,2017-01-01,2017-12-31,2020-02-18 16:27:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-13.19
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,753200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,753200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-1006200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-1006200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1759400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-335800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-890300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-882100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-1616700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8041700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-4197300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,119500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1639900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-279300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-60400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1373100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1592000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3231900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1698300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5655700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10585900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-385300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10215100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10151400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,333800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,333800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,333900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-2.1
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4034300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4034300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1173000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1173000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2861300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,614100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1665600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1289200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3562000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4034300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7749600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10846200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7984900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2620600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3102000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11086900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3277600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7809300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-6100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7821500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,3400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7894500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-12.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-12.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,654100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.07
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 07:03:00+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.7
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15187500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15187500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3174200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3174200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12013300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1837700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4405100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4434500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8813800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8041700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8125000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19574400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7561100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1374900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,128100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4810400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6057200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13618300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4972100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5655700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14301900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-17600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14334000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,208800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14555300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-22.3
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-22.3
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,654100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-22.3
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.1
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15652500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15652500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1777900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1777900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13874600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2277700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5241900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6091700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,1398600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8862600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-8041700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,7837100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23667900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9793300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1667600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,174500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4775400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6268500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16061800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6043300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5140800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15159300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31540100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-15105600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1269100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,275300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,983900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-21.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,333500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-21.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,654100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-21.73
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.1
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4007400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4007400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1100400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1100400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2907000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,907500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1870400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2385400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3515800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4007400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,28000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4699700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1792700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,554800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-267000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-768000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2560700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1162400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1398300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1415100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,69600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1488700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,628100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 19:24:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.7
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11153200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11153200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2001200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2001200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9152000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1223600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2739500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3145300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5251800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4007400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,375400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8728200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,423800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,844500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,79100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2189800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2955200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2531400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1694500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5655700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6492600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-11500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-8400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6512500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,139200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6660800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-10.23
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-10.23
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,628100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-10.23
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.4
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15240400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15240400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,604900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,604900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14635500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2024800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,4372300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5425300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,1860800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6909700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4007400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,124800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16710300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2074800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1461500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2121200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3439100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5513900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2924600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5140800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7730100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31546200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-15105600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8710500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,270200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8426900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,28.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,335200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,28.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,628100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,28.92
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.4
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14917800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14917800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-54000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-54000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14971800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1460500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3368700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3676400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,1860800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5027000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,348100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15741500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-769700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1252500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,92300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1704100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2864300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3634000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2020400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-5140800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6754400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,31477300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-15097200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9625700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,270200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9344300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,335100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,29.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,335100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,29.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,658000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,29.85
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.7
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15787400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15787400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15787400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1271200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3250600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3070800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,2191400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6552300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5698700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22035000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6247600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,911200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,45200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,256700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-609300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6856900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1770700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4761900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-324300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4761900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5086200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,10200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5096400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,337000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-15.26
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,337000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-15.26
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,334000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-15.26
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,FY,2018-01-01,2018-12-31,2020-02-18 16:27:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3911400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3911400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,596800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,596800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3314600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,289200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,755600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,424200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1588500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,-400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3057100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,257500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,220400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,130000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-80400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,177100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,213400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,339000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,339000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,344500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:00:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11707700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11707700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1601400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1601400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10106300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,919200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2409000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2386100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4983200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,272300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10969800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-863500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,701000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,266600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-400800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1264300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-474000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-790300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-790300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-842900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,339000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,339000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,344500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.49
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4124200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4124200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,481800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,481800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3642400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,334100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,853400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,965200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1697100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,259600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4109400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-467000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,230000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,215400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-475300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-470100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-470100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-472500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.39
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.39
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,339900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2,2018-04-01,2018-06-30,2019-08-08 17:29:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.39
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7796300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7796300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1004600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1004600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6791700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,630000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1653400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1961900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3394700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,272700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7912700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1121000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,480600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,136600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-320400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1441400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-687400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-754000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-754000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-805000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.38
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.38
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,339900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.38
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3672100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3672100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,522800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,522800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3149300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,295900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,800000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,996700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1697600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,13100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3803300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-654000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,250600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,17300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-78800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-312100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-966100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-682200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-283900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-283900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-332500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,334600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.99
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,334600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.99
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,335900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.99
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 17:25:39+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16088900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16088900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16088900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2481800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3461700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2248000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,2493100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5856600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3993000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20534200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4445300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,783000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-673400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5118700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,146400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5114100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-151000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-5114100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5265100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5271000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,329000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-16.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,329000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-16.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,329000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-16.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,FY,2019-01-01,2019-12-31,2020-02-18 16:27:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4050700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4050700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,639000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,639000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3411700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1092700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,901400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,474500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1537700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4008300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-596600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,193900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-170900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-767500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-785600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-785600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-786800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,328000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.4
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,328000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.4
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:00:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.4
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11737900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11737900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1789100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1789100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9948800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1725200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,2578700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1795500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4339100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3679000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14117500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4168700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,591100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-528000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4696700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,251100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4947800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4947800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12967500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17921300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,328000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-15.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,328000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-15.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-15.02
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4090100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4090100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,652300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,652300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3437800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,324200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,873300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,886000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1402000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1215200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4700700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1262900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,195400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-190400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1453300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,301600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1754900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1754900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,0.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1759000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,327600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2,2019-04-01,2019-06-30,2019-08-08 17:29:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.37
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7687200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7687200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1150100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1150100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6537100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,632500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1677300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1321000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2801400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3677000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10109200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3572100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,397200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-357100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3929200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,233000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4162200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4162200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12967500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17134500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-12.62
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,327800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-12.62
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,327600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-12.62
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3597100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3597100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,497800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,497800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3099300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,308300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,804000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,435000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1399400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2461800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5408500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2309200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,201800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-166700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2475900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-68600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2407300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2407300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12967500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15375500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,332000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.25
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,332000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.25
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2120800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.25
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 08:03:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.74
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15712400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15712400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-25000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-25000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15737400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1283600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3254600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2509100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,2191400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6254100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8147400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23640200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7902800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,862400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,349300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-463900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8366700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1157100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,4761900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2447700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-4761900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7209600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,-46400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,12967500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20139400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,332000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-21.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,332000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-21.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2120800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-21.52
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16096200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16096200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,125300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15970900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2574800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,3629800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2243000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,explorationexpense,Exploration Expense,+,debit,usd,2493100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,5873600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2592300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19406600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3435700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,765700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,76700000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-694900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4130600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1651800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,5114100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2635300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-5114100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2478800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-15407000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12922000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,329100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.62
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,331900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.63
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2450000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.62
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3604400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3604400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,623100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,623100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2981300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,401300000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,972100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,430000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1416400000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1061100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4280900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1299600000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,184500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-24900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-188200000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1487800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1866800000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,379000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,379000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,netincometocommon,otheradjustmentstonetincometocommon,Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders),-,debit,usd,-2439500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2817500000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,329100000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,331900000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2450000000.0
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Allergan plc,AGN,6T6CAG8O6TSUTMO6BA21,0001578845,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 08:03:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.74
